Uptake of the parkinsonism-inducing toxin, 1-methyl-4-phenylpyridinium (MPP + ), into dopaminergic terminals is thought to block Complex I activity leading to ATP loss and overproduction of reactive oxygen species (ROS). The present study indicates that MPP + -induced ROS formation is not mitochondrial in origin but results from intracellular dopamine 
INTRODUCTION
The neuropathological hallmark of Parkinson's disease (PD) is an irreversible loss of dopamine (DA)-containing neurons in the substantia nigra. Although the underlying cellular and molecular events in PD are still unknown, post-mortem studies suggest that both oxidative stress and impaired energy metabolism are involved (review, 1). Because the neurotoxin 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) has been shown to produce parkinsonian symptoms in primates and rodents (review, 2), it has been extensively used as an animal model of PD. Thus, elucidation of its mode of action has been of paramount importance in understanding and potentially treating this disorder. Towards this end, studies have indicated that l-methyl-4-phenylpyridinium (MPP + ), the active metabolite of MPTP, can block electron transport by binding to the same site as the classic Complex I inhibitor, rotenone, leading to a loss of ATP production (3) (4) (5) (6) (7) . Rotenone or MPP + also produce superoxide anions in submitochondrial particles (8) (9) (10) (11) , adding further support to the basic premise that MPP + acts primarily as a mitochondrial toxin.
However, MPP + does affect other processes. For example, MPP + rapidly induces DA release and subsequent formation of hydroxyl radicals both in vivo and in vitro (12) (13) (14) (15) (16) (17) .
Because the timing of this process is comparable to exocytosis (18) , the deleterious effects of extracellular DA oxidation may actually precede mitochondrial dysfunction, which occurs more slowly (6, 19) . Moreover, the rapidity of this process suggests that MPP + releases DA from intracellular pools versus toxin-induced degeneration of dopaminergic terminals.
Role of dopamine in MPP + toxicity
From what intracellular pool does MPP + release DA? In addition to being taken up by the plasma membrane DA transporter (DAT; 20) , MPP + also undergoes high affinity uptake by the vesicular monoamine transporter (VMAT2; [21] [22] [23] . Indeed, fractionation studies in chromaffin cells have shown that MPP + is predominantly localized within catecholaminergic vesicles with only negligible amounts found in mitochondria (24) . Because VMAT2 overexpressing cell lines are resistant to MPP + (25, 26) , sequestration within vesicles appears to play a protective role. Consistent with this hypothesis, heterozygous VMAT2 knock-out mice display increased susceptibility to MPTP (27, 28) .
A consequence of sequestration, however, might be the displacement of DA from vesicular stores. Once in the cytoplasm, DA would be readily autoxidized (review, 29) or deaminated (30) to produce hydrogen peroxide, superoxide, and reactive quinone species capable of covalently modifying cellular macromolecules (31) . Thus, MPP + -mediated displacement of DA from secretory vesicles could not only lead to cytoplasmic DA oxidation and generation of free radicals but also to extracellular DA release and oxidation, both of which could contribute to dopaminergic neuronal degeneration.
Given the alternative and possibly overlapping hypotheses as to the source and sequelae of MPP + -induced free radicals, the present study used free radical sensitive fluorophores together with pharmacological and molecular techniques to determine the role of DA in MPP + -mediated toxicity in primary dopaminergic neurons.
Role of dopamine in MPP + toxicity EXPERIMENTAL PROCEDURES Mesencephalic Cultures. Cultures of murine (CF1; Charles River Laboratories) mesencephalic neurons were prepared as previously described (32) . For immunocytochemistry, cells were plated at a density of 100,000 cells per glass microwell plate (1.25 X 10 3 cells/mm 2 ). For DA release/content assays, cells were plated at a density of 400,000 cells per 16 mm well (2 X 10 3 cells/mm 2 ). Experiments were conducted after 6 days in vitro unless otherwise specified.
Chemicals. 1-methyl-4-phenylpyridinium (MPP + ) iodide, DL-α-methyl-p-tyrosine (MPT), mazindol, nifedipine, and reserpine (RES) were purchased from Research Biochemicals International (Natick, MA). Dihydroethium (DHE), rotenone, 3-hydroxytyramine (dopamine), 5,7-dihydroxytryptamine (5,7-DHT), and succinate were obtained from Sigma (St. Louis, MO). Dihydrorhodamine (DHR) and rhodamine 123 (R123) were purchased from Molecular Probes (Eugene, OR). The C 3 isomer of malonic C 60 was a kind gift from Dr. L. Dugan (Department of Neurology, WUMS; 33). [7,8-3 H] -dopamine was purchased from Amersham Pharmacia Biotech (Piscataway, NJ). C 3 was dissolved in water, 5,7-DHT was dissolved in 1% ascorbic acid, mazindol was first dissolved in 50 mM HCl and then diluted in media. Reserpine, rotenone, and the fluorophores were dissolved in DMSO as stock solutions and then diluted in media such that the final concentration of DMSO was <0.1%. Controls for each drug condition consisted of sister cultures treated with the vehicle used to dissolve that drug.
Imaging. In order to monitor intracellular superoxide formation in response to MPP + and rotenone, we used the redox-sensitive dye DHE which is converted into fluorescent ethidium by superoxide anions (34) (35) (36) . Cells were incubated with DHE for 20' at 37 o C, rinsed, fixed and processed for tyrosine hydroxylase (TH) immunocytochemistry. For TH staining, an alkalinephosphatase-mediated color reaction was used instead of fluorophore conjugation in order to prevent bleed-through fluorescence from the TH staining procedure. TH positive neurons were identified at 60X using differential interference contrast. Cellular DHE fluorescence (Ex=488 nm; Em=595 nm) was imaged using a laser-scanning confocal microscope (Noran Odyssey) and measured using an image analysis system (Metamorph, Universal Imaging). Measurements were normalized to DHE fluorescence from untreated dopaminergic neurons. Although pre-treatment with MPT or reserpine decreased basal DHE fluorescence by 18% and 22%, respectively, their attenuation of MPP + -induced oxidation was greater than could be accounted for by this decrease. To ensure that rotenone does not induce the production of other ROS, like hydroxyl and peroxynitrite, we used the fluorescent dye dihydrorhodamine (DHR) as previously described (32) . Briefly, dopaminergic neurons were identified with the autofluorescent serotonin analog 5,7-DHT, stained with 15 µM DHR for 20' at 37 o C, and imaged (Ex=488 nm; Em>515 nm).
Cells were then fixed and stained for TH, and field relocation was used to confirm that 5,7-DHT cells were indeed dopaminergic. To exclude the possibility that enhanced DHE fluorescence was an artifact of decreased mitochondrial membrane potential (∆Ψ m ; 35), we monitored changes in ∆Ψ m following both rotenone and MPP + treatment using the fluorescent, potentiometric dye rhodamine 123 (R123). Cells were stained with 5,7-DHT and 0.3 µM R123 and imaged exactly Role of dopamine in MPP + toxicity as previously described (32) . Determination of Cell Viability. To determine dopaminergic cell viability following MPP + -treatment, mesencephalic cultures were processed for TH immunoreactivity and counted as previously described (32) . Briefly, 6 consecutive fields were assayed per dish leading to the quantification of 200-300 TH neurons per experiment. Experiments were repeated 3-5 times using cultures isolated from independent dissections. Statistical Analysis. Descriptive statistics (mean ± SEM) of cell survival counts were calculated with the statistical package GraphPad Prism Software. Cell survival curves were generated using the mean ± SEM with data collected from at least three separate experiments. The significance of effects between control and drug conditions was determined by one-or two-way factor ANOVA as indicated, and post-hoc Student's t tests (GraphPad Prism Software).
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RESULTS
MPP + -induced reactive oxygen species (ROS) are not mitochondrial in origin.
Overproduction of ROS has been proposed to be an important mechanism underlying the cytotoxicity of MPP + (39) (40) (41) 32) . In support of this model, our previous studies have shown that doses of MPP + capable of killing 70% of cultured dopaminergic neurons produced an early, 3-fold increase in superoxide radicals (32) . Given that mitochondria are a major cellular source of ROS (review, 42) and that MPP + is thought to block Complex I activity, it has been hypothesized that MPP + -induced ROS are mitochondrial in origin. Since MPP + and rotenone are thought to bind to the same site on Complex I (5, 7), then rotenone should also induce superoxide production.
Although high concentrations of rotenone have been shown to induce superoxide production in vitro and in vivo (8) (9) (10) 43) , other studies have suggested the converse (44) (45) (46) .
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To determine whether rotenone mimicked MPP + -induced changes in mitochondrial function, we monitored mitochondrial membrane potential (∆Ψ m ) and free radical production in response to this drug. Specific changes in dopaminergic neurons were determined by either pre-loading cells with the monoaminergic-specific, autofluorescent dye 5,7-DHT as previously described (32) or by post-hoc identifying cells using TH immunocytochemistry. For example, the ethidium cation released from DHE, a dye widely used to monitor superoxide production (34) (35) (36) , can be stably intercalated into DNA. This property allowed DHE-treated cultures to be subsequently stained for TH. Fields containing TH positive were then imaged by confocal microscopy.
Low doses (5-50 nM) of rotenone killed dopaminergic neurons (LD 50 =20 nM ± 5.2) with a similar time course and morphology to MPP + ( Fig. 1; 32 ). Despite the loss of cell viability, rotenone-treated dopaminergic neurons did not exhibit an increase in intracellular superoxide levels at any time point studied ( Fig. 2A, C) . Moreover, subtoxic doses of rotenone as well as doses capable of killing up to 75% of the dopaminergic population had no effect on superoxide generation (not shown). In contrast, dopaminergic neurons treated with a mean lethal dose of MPP + exhibited a robust increase in superoxide that reached a plateau between 1-3 h ( Fig. 2A, B ; 32). DHE fluorescence was punctate in appearance and localized to mitochondria.
To exlude the possibility that enhanced DHE fluorescence was an artifact of mitochondrial membrane depolarization and dequenching of the dye (35), we monitored changes in ∆Ψ m following both rotenone and MPP + treatment using the fluorescent, potentiometric dye Role of dopamine in MPP + toxicity rhodamine 123 (R123). No significant change in ∆Ψ m was observed in cells treated with MPP + (Fig. 2B ) whereas rotenone-treated cells displayed a small, significant increase in ∆Ψ m after 3 h of drug exposure (Fig. 2C) . The latter finding is similar to reports by others suggesting that low (nM) to moderate (<5 µM) doses of rotenone have either no effect on ∆Ψ m (45, 46) or lead to a modest hyperpolarization (47, 48) . These data support earlier observations that following Complex I blockade ∆Ψ m is maintained by hydrolysis of glycolytic ATP via reversal of the ATP synthase (44, 49) .
Because ∆Ψ m was not dissipated by MPP + or rotenone, we used the fluorescent dye dihydrorhodamine (DHR) as an independent measure of free radical formation (50, 51). As we have shown previously, MPP + exposure led to a significant increase in DHR fluorescence in identified dopaminergic neurons, whereas rotenone led to a modest but significant decrease in DHR oxidation (Fig. 3) . Therefore, since the classic Complex I inhibitor rotenone did not induce ROS as indicated by two independent methods, we conclude that MPP + -induced superoxide does not arise from blockade of electron transport.
MPP + displaces DA from storage vesicles and leads to reverse transport via the plasma membrane DA transporter.
Numerous slice and in vivo studies have shown that MPP + induces a massive, rapid outflow of DA that can subsequently be oxidized (13, (15) (16) (17) . These data prompted us to assess whether this process also occurred in our simplified dopaminergic culture system and, if so, what Role of dopamine in MPP + toxicity the source and export mode of DA might be. Following treatment with 1 µM MPP + , rapid reductions in intracellular DA were observed which remained depressed >16 h (not shown).
Concomitantly, extracellular DA levels rose (Fig. 4A) . Brief (5') pre-treatment with 10 µM reserpine, a VMAT2 inhibitor, almost completely blocked MPP + -induced DA release (Fig. 4B) , whereas lower doses of reserpine (10 and 100 nM) did not. In agreement with striatal slice studies (14, 53) , pre-treatment with the general calcium channel blocker, CdCl 2 (100 µM), or the specific calcium channel blocker, nifedipine, did not affect MPP + -induced DA release excluding a Ca 2+ -dependent, exocytic process (Fig. 4B) . In contrast, 10 µM mazindol, a DAT inhibitor, significantly blocked toxin-mediated release suggesting that, upon vesicular displacement, DA is extruded from the cell by reverse transport via the plasma membrane DAT (Fig. 4C) . Predictably, DAT blockade was accompanied by an increase in intracellular DA content (Fig. 4D) . Thus, in this paradigm, MPP + redistributes vesicular DA to the cytoplasm followed by its outward transport through the DAT.
MPP + -induced superoxide formation results from DA oxidation.
Since redistributed DA can be easily autoxidized to produce a variety of ROS, including superoxide anions, we hypothesized that MPP + -induced superoxide production arises from DA metabolism. To test this hypothesis, cells were depleted of both stored and newly-synthesized DA using the VMAT2 blocker reserpine and the TH inhibitor α-methyl-p-tyrosine (MPT).
Incubation of cells with either 100 µM MPT or 10 nM reserpine for 3 h led to 75-80% depletion of intracellular DA (DA content with MPT was 24.72 % ± 5.91 of control, with reserpine Role of dopamine in MPP + toxicity 22.54% ± 2.02 of control). Because reserpine and MPT concentrations exceeding 100 nM and 1 mM, respectively, were toxic over a prolonged period of time, the minimum effective dose needed to deplete DA was used.
MPP + treatment resulted in a significant increase in superoxide that could be fully blocked by the general free radical scavenger, carboxyfullerene isomer C 3 ( Fig. 5A, B; 33) .
Interestingly, treatment with reserpine or MPT also blocked DHE fluorescence suggesting that redistributed DA is the major contributor to MPP + -generated superoxide (Fig. 5A, B) . In this set of experiments, MPP + led to a lower increase in superoxide formation than previously observed ( Fig. 2; 32 ) which was correlated with decreased toxicity (<50%; not shown). Presumably this was due to lot-to-lot variation in the toxin since 1 µM MPP + typically killed 50-70% of dopaminergic neurons.
To further test the hypothesis that DA oxidation serves as the source of MPP + -induced ROS, cells were treated with MPP + for a period of time sufficient to release DA (10'; Fig. 4C) but not to increase superoxide levels (Fig. 5C ) nor to affect neuronal viability (Fig. 6C) .
Following this brief MPP + exposure, reverse transport of cytoplasmic DA was blocked by the DAT inhibitor mazindol (Fig. 4C) . The resulting accumulation of cytoplasmic DA led to an 80% increase in superoxide formation whereas the same MPP + treatment without mazindol inclusion did not (Fig. 5C ). Taken together, these data indicate that MPP + -generated superoxide arises directly from DA oxidation. To test whether manipulation of DA levels would attenuate MPP + -induced cell death, cells were depleted of intracellular DA using MPT or reserpine for 3 h prior to treatment with various doses of MPP + . DA depletion using either reagent significantly attenuated MPP + -induced cell death at every dose of MPP + tested (Fig. 6A) . For instance, at 1 µM MPP + , MPT and reserpine attenuated cell death by 48% and 56%, respectively. Conversely, increasing intracellular DA levels exacerbated MPP + toxicity. For example, cells were briefly pre-loaded with 5 µM DA, which increased intracellular DA content 5-fold (460.5% ± 7.2 compared to control), and then exposed to a low dose of MPP + for 48 h. DA pre-treatment led to a 34% increase in MPP + -induced cell death compared to cells treated with MPP + only (Fig. 6B) . In contrast, brief treatment with DA alone had no significant effect on cell viability after 48 h.
To test whether cytoplasmic or extracellular DA is involved in MPP + toxicity, cultures were briefly treated with MPP + in order to displace vesicular DA (Fig. 4A) . Reverse transport was then blocked with mazindol and viability was assessed 48 h later. A brief exposure to MPP + alone followed by extensive washing did not significantly alter cell viability after 48 h (Fig. 6C) .
Co-incubation with mazindol and MPP + , however, resulted in a 38% decrement in the number of TH-immunoreactive cells suggesting that redistributed cytoplasmic DA, and not extracellular DA, contributes to MPP + toxicity in vitro. In agreement with others (53-55), pre-treating cells with mazindol and then adding MPP + completely abrogated toxin-induced cell death (Fig. 6C ).
Mazindol alone had no effect on cell viability at 24 h. Taken together, these results indicate that (Fig. 6D) suggesting that a mean lethal dose of this toxin kills cells by two mechanisms: DA-dependent ROS production and ATP depletion.
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DISCUSSION
Although widely used as an animal model of PD, the mechanism by which MPP + kills cells remains equivocal. Previously, we have shown that cultured dopaminergic neurons exposed to MPP + exhibit a non-apoptotic type of cell death that is partially mediated by reactive oxygen species (ROS; 32). The present study demonstrates that, contrary to current hypotheses, MPP + -induced free radical formation is not mitochondrial in origin but, rather, arises from DA oxidation within the cytoplasm following its displacement from vesicular storage sites.
Redistributed DA is directly linked to ROS production and cell death. Thus, besides energy impairment, DA-dependent oxidative stress is an important contributor to MPP + toxicity.
Previous studies have reported that rotenone induces NADH-dependent superoxide formation (8-10) in addition to decreasing ∆Ψ m (43, 58) . In contrast, various groups have failed to detect superoxide production and ∆Ψ m depolarization in response to rotenone (44-46, 49, 59) .
In the latter model, utilization of glycolytic ATP is thought to maintain ∆Ψ m via reversal of the ATP synthase (review, 59). In agreement with the latter reports, treatment of dopaminergic cultures with rotenone did not depolarize the mitochondrial membrane potential nor did it induce ROS formation as measured by two independent fluorophores (Figs. 2, 3) . MPP + , which binds to the same site on Complex I as rotenone (5, 7) also did not alter ∆Ψ m (Fig. 2 and 32) . However, Role of dopamine in MPP + toxicity in contrast to rotenone, MPP + generated a significant, rapid burst in ROS as measured by DHE or DHR oxidation (Fig. 2, 3; 32) . Since MPP + is not typically known to affect other respiratory complexes (review, 60), these data suggest that MPP + -generated ROS are not mitochondrial in origin.
Fluorescent dyes are prone to many types of artifacts including quenching, diffusion, etc.
(59). Frequently, this is due to mitochondrial membrane depolarization and subsequent fluorescence dequenching. Alternatively, agents which induce the mitochondrial permeability transition may also generate an apparent increase in ROS due to depolarization (reviews, 61-63).
Conceivably, MPP + -induced ROS might arise via either of these mechanisms. Indeed, recent studies conducted in isolated liver mitochondria (43, 64) have suggested that MPP + can open the permeability transition pore. However, in the present study, MPP + treatment concomitantly increased ROS but did not affect ∆Ψ m (Fig. 2) . Thus, artifactual ROS induction seems unlikely.
Moreover, many studies have documented differences between peripheral and CNS-derived mitochondria (61, (65) (66) (67) . Therefore, parallels between them must be viewed with caution.
Finally, additional support for the finding that MPP + generates ROS from non-mitochondrial sources comes from studies showing that mice overexpressing the cytoplasmic (Cu/Zn) form of superoxide dismutase are more resistant to MPTP toxicity than their wild-type littermates (39) . This is in contrast to mice overexpressing the mitochondrial (Mn) form of the enzyme which exhibit only a modest degree of protection (68) . Presumably, the reverse would be true if MPP + induced mitochondrial ROS. Besides mitochondria, there are other cellular sources of ROS generation. One source unique to dopaminergic neurons is DA itself. In the cytoplasm, DA oxidation generates hydrogen peroxide and various reactive quinone species (review, 29). Superoxide per se is not extremely reactive. However, it is thought to be rapidly converted into other ROS such as peroxynitrite and H 2 O 2 , which, in the presence of transition metals, can be converted to hydroxyl radicals (review, 69). These products might be expected to generate a variety of aberrant oxidative metabolites of DA including 6-hydroxydopamine (70), 5-S-cysteinyl-DA (29, 31) , and other more complex dihydrobenzothiazines (71, 72) . Several of these compounds can also inhibit Complex I further affecting energy impairment (67) . Although the present studies have emphasized the role of intracellular DA in neurotoxicity, in vivo studies have established that MPP + -mediated efflux of DA also generates extracellular hydroxyl radicals (17) . Indeed, DA can be toxic both in vitro (31, 73) and in vivo (74, 75) . In our paradigm, however, toxin-induced DA release led to accumulation of extracellular DA only in the picomolar range, whereas concentrations higher than 10 µM were necessary to induce toxicity in our cells (not shown). Thus, the low-density nature of these cultures may preclude the development of harmful levels of extracellular DA, a process which is more likely to occur following in vivo MPTP treatment.
What intracellular pool of DA is mobilized upon MPP + treatment? Studies utilizing VMAT2 knock-out mice have confirmed the notion that DA is stored primarily in synaptic vesicles (76) . Since MPP + has a high affinity for VMAT2 (21) (22) (23) and can be taken up into catecholaminergic vesicles (24, 77, 78) , it conceivably redistributes DA from its storage sites to Role of dopamine in MPP + toxicity the cytosol. This hypothesis was proposed more than a decade ago although subsequent studies (e.g. 79) failed to support it. Rather, the idea has emerged that vesicular uptake of MPP + solely abrogates its mitochondrial import. The latter view was bolstered by studies showing that heterozygous VMAT2 knock-out mice appear to be more sensitive to MPP + than their wildtype littermates (27, 28) .
The present findings can be reconciled with these data by invoking a multi-modal model. Accordingly, MPP + can be sequestered within vesicles but can also lead to the disruption of the vesicular mileau such that DA is displaced. This event would be indiscernible in VMAT2 knock-out animals since disruption of vesicular storage would affect not only MPP + uptake but DA uptake as well (76, 80) . Increased cytoplasmic DA pools would be subject to enhanced degradation as well as oxidation. DA oxidation combined with the cytoplasmic accumulation of MPP + would indeed potentiate the drug's toxicity.
The effects of MPP + on VMAT2-impaired mice are reminiscent of earlier experiments suggesting that reserpine can potentiate MPP + toxicity (79) . In these experiments, µM levels of reserpine were used which would have not only depleted vesicular DA stores but also blocked the vesicular uptake of MPP + (K i = 1.6 µM; 23). Hence, the same phenomena would have occurred: increased cytoplasmic DA pools available for oxidation together with a nonsequestered toxin. In contrast, in the present paradigm, pre-treatment with low doses of reserpine (<10 nM) safely depleted stored DA prior to the cellular uptake and distribution of MPP + and thus reduced MPP + -induced ROS formation (Fig. 5) and cell death (Fig. 6) . In vivo Role of dopamine in MPP + toxicity support of this model comes from a recent microdialysis study demonstrating that pre-treatment with reserpine prevented MPP + -mediated DA release in a dose-dependent fashion (81).
Redistributed, cytoplasmic DA could be released by reverse transport, a DAT-dependent process (82, 83) . In accordance with this model, MPP + -induced DA release was reduced in the presence of the DAT inhibitor mazindol (Fig. 4C) and was not dependent upon Ca 2+ entry (Fig.   4B ). Such a paradigm is strikingly similar to that proposed for the psychostimulant Damphetamine which also displaces DA from pre-synaptic storage sites and induces reverse transport via the transporter (84, 85) . Thus, it is conceivable that certain aspects of MPP + -mediated toxicity overlap with those of D-amphetamine.
DAT kinetic properties have been extensively studied in both isolated (e.g. 86) and intact preparations (e.g. 85, 87) . Of interest, are real-time voltammetric studies indicating that the accumulation of cytoplasmic DA released from vesicles is not sufficient to trigger DATmediated efflux (86, 87) . The ability of AMPH and other structural analogues to promote DA transport out of the cell is apparently due to conformational changes in the DAT such that more "inward-facing" transporters are available to carry DA in the outward direction (85, 87) .
Whether MPP + operates in a similar fashion remains to be elucidated.
Although energy depletion due to electron transport inhibition is the best established mechanism associated with MPP + toxicity (review, 60), the present findings emphasize that energy depletion as well as DA oxidation contribute to the demise of dopaminergic neurons (Fig.   6 ). At mean lethal doses of toxin, complete rescue from MPP + toxicity is only achieved when cells are depleted of DA in the presence of the Complex II substrate, succinate (Fig. 6D) . These Errors of less than 2% are buried within the symbols. Role of dopamine in MPP + toxicity
